One in ten women are taking weight loss medication, while almost three quarters are “considering” it, a survey has found.
A survey of 1,000 women, aged between 30 and 75, found that the majority were considering taking products such as Wegovy and Mounjaro to help them lose weight this year.
But many women admitted they would only do it secretly to avoid the “stigma” surrounding weight loss that wasn’t just the result of diet and exercise.
Of those taking them, one in five (19 percent) admitted they were taking medication without others knowing, while more than a third (35 percent) said they would only tell those closest to them. they.
Nearly nine in ten (86 percent) said they had tried multiple diets and weight loss programs to lose weight.
Difficulty maintaining a consistent diet was the biggest barrier to losing weight, followed by lack of time to exercise regularly and mental health or motivation challenges, according to findings commissioned by digital weight loss service Juniper.
More than 500,000 people in the UK now receive weight-loss injections, and the majority come from private pharmacies.
The Obesity Health Alliance (OHA) estimates that 4.1 million people in England are eligible for Wegovy on the NHS, which requires a BMI of at least 30 and at least one related health condition, such as type 2 diabetes.
One in ten women are taking weight-loss drugs, while nearly three-quarters are “considering” it, survey finds
A survey of 1,000 women, aged between 30 and 75, found that the majority were considering taking products such as Wegovy and Mounjaro to help them lose weight this year.
In this photo illustration, injection pens and boxes of the weight loss drug Wegovy from Novo Nordisk are shown.
But so far only a few thousand are thought to receive it through specialist NHS weight management services, with the rest usually using online pharmacies.
The NHS has started prescribing Mounjaro but has been limited to 220,000 patients over the next three years, amid fears over cost and deliverability.